Huaren Shuanghe and others established a biopharmaceutical industry fund investment enterprise in Hohhot.

According to the Qichacha APP, a recently established investment partnership enterprise called China Resources Shuanghe Biomedical Industry Fund has contributed 500 million yuan. Its business scope includes equity investment, investment management, asset management, and other related activities as a private equity fund. Through equity penetration on Qichacha, it is shown that this enterprise is jointly invested by China Resources Shuanghe, China Resources Pharmaceutical Investment Co., Ltd., and China Resources Medical Equity Investment Fund Management Co., Ltd.